Morgan Stanley analyst Mark Purcell raised the firm’s price target on AstraZeneca to 14,500 GBp from 14,000 GBp and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
